Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P31749 (
AKT
)
22,954
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Protein phosphatases play a crucial role in cell cycle progression, cell survival, cellular signaling, and genomic integrity. The protein phosphatase 1 (PP1) regulatory subunit
SDS22
plays a significant role in cell cycle progression. A recent study showed that
SDS22
plays a vital role in epithelial integrity and tumor suppression in Drosophila. However, its tumor suppressive activity remains obscure in the mammalian system. Here, for the first time, we show that
SDS22
inhibits the growth of breast cancer cells through induction of apoptosis.
SDS22
negatively regulates the
AKT
kinase signaling pathway through PP1.
SDS22
associates predominantly with
AKT
and dephosphorylates the phospho Thr308 and phospho Ser473 through PP1 and hence abrogates the cell migration, invasion, and tumor growth. Thus, our study deciphers the long-standing question of how PP1 negatively regulates the
AKT
signaling pathway. Further, we observed a significant converse correlation in the expression levels of
SDS22
and phospho form of
AKT
with reduced levels of
SDS22
in the higher grades of cancer. Overall, our results suggest that
SDS22
could be a putative tumor suppressor and replenishment of
SDS22
would be an important strategy to restrict the tumor progression.
...
PMID:Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway. 3050 Jun 80